Aerpio Pharmaceuticals, Inc. (NasdaqCM:ARPO)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the merger of ARPO with Aadi Bioscience, Inc.
If you are an investor, and would like information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
Altabancorp (NasdaqCM:ALTA) – Glacier Bancorp, Inc. (NasdaqGS:GBCI)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the merger of ALTA with GBCI.
If you are an investor, and would like information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
SPAC Market is Healthier Than Most Think thestreet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thestreet.com Daily Mail and Mail on Sunday newspapers.
Inflation News Hits SPACs, Pershing Square Tontine Surges
The 4% YoY CPI jump dominated market news and sent stocks and SPACs both sliding. Switchback s Bird deal flopped and Ackman boosted PSTH.
Author:
The two deals announced this morning were a mixed bag, though both are still trading at significant discounts to NAV, and certainly lacking punch:
-
-
+2.17% to $9.89
It s very tough to announce a deal in such difficult market conditions, so perhaps we will see CENH trade above NAV as equity markets recover. On a really tough day overall for stocks following this morning s CPI print, SPACs were not immune to the selloff. Current pre-deal SPACs are
Two Big SPAC Deals (SRNG, AURC) After Monday s Mess
Monday was a painful day for SPAC investors with 75% of pre-deal SPACs dropping farther and 3 deals actually dropping on the news. Will today s deals from SRNG and AURC turn the tide?
Author:
At the close yesterday the average pre-deal SPAC was at $9.87 even further from NAV than investors have seen in a long time. Even worse, the three morning deals all closed lower:
-
-
LIV Capital (LIVK) -0.1% to $9.99
Today s two deal announcements are mega deals and could potentially turn the tide, but given the market s overall state and SPACs still being clogged, it will take a lot.
SPACs Hit Hard on Merger Monday
Four deals were announced, but performance was underwhelming. Given the overall market s bad day, it s no surprise 75% of pre-deal SPACs declined and now average $9.87.
Author:
Merger Monday returned with four new announced SPAC deals, but ultimately ended in a bit of a thud as all three SPAC stocks that announced this morning fell on the day. More broadly, 75% of Pre-Deal SPACs declined, closing at an
average of $9.87.
-
-
LIV Capital (LIVK) -0.1% to $9.99
The deal selloffs came amid a broader market decline as well - so it s tough to attribute the lack of performance solely on deal conviction - yet most of newly announced deals have not been trading with much enthusiasm. However, as we ve been saying, given there are